TERT promoter mutations in patients with BRAF(V600)-mutated melanoma treated with vemurafenib or cobimetinib combined with vemurafenib Meeting Abstract


Authors: Wongchenko, M. J.; Larkin, J.; McArthur, G. A.; Ribas, A.; Dreno, B.; Chapman, P. B.; Maio, M.; Garbe, C.; Robert, C.; Lu, W.; Diala, I.; Darbonne, W. C.; Chang, I.; Hsu, J. J.; Caro, I.; Rooney, I.; Ascierto, P. A.; Yan, Y.
Abstract Title: TERT promoter mutations in patients with BRAF(V600)-mutated melanoma treated with vemurafenib or cobimetinib combined with vemurafenib
Meeting Title: 16th World Congress on Cancers of the Skin (WCCS)
Journal Title: Melanoma Research
Volume: 26
Issue: e-Suppl.
Meeting Dates: 2016 Aug 31-Sep 3
Meeting Location: Vienna, Austria
ISSN: 0960-8931
Publisher: Lippincott Williams & Wilkins  
Date Published: 2016-08-01
Start Page: e40
End Page: e41
Language: English
ACCESSION: WOS:000383560800076
PROVIDER: wos
DOI: 10.1097/CMR.0000000000000285
Notes: Meeting Abstract: P058 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paul Chapman
    326 Chapman